Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print March 23, 2007
DOI: 10.2337/dc06-1331

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-1331v1
30/6/1544    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abdul-Ghani, M. A.
Right arrow Articles by Stern, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abdul-Ghani, M. A.
Right arrow Articles by Stern, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

What Is The Best Predictor Of Future Type 2 Diabetes?

Muhammad A. Abdul-Ghani, MD, PhD1, Ken Williams, MS1, Ralph A. DeFronzo, MD1 and Michael Stern, MD1

1Divisions of Diabetes and Clinical Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio, TX

albarado{at}uthscsa.edu

ABSTRACT

Aim:: To assess insulin secretion/insulin resistance index in predicting the risk for future T2DM

Experimental Design and Methods:: 1551 non-diabetic subjects from the San Antonio Heart Study received an OGTT with measurement of plasma glucose and insulin concentrations at 0, 30, 60, and 120 minutes at baseline and after 7-8 years of follow-up. Insulin secretion/insulin resistance index was calculated as the product of Matsuda index and {Delta}I0-30/{Delta}G0-30 or {Delta}I0-120/{Delta}G0-120. The discriminatory power of various prediction models for development of T2DM was tested with the area under the receiver-operating characteristics (ROC) curve.

Results:: Insulin secretion/insulin resistance index (0-30 and 0-120 min time periods) had the greatest areas under ROC (0.85 and 0.86, respectively), which were significantly greater than the 2-h plasma glucose concentration during the OGTT or The San Antonio Diabetes Prediction Model (SADPM) (P<0.001 and P<0.0001, respectively). A model based on the combination of the SADPM model and a modified version of the insulin secretion/insulin resistance index or 1-h plasma glucose concentration had equal power to predict the risk for future T2DM compared to the insulin secretion/insulin resistance index.

Conclusion:: The insulin secretion/insulin resistance index is useful as a predictor of future development of T2DM. A model based upon the combination of the SADPM model and either a modified version of the insulin secretion/insulin resistance index or 1-hour plasma glucose concentration can equally predict future T2DM.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
R. Baratta, P. Rossetti, S. Prudente, F. Barbetti, D. Sudano, A. Nigro, M. G. Farina, F. Pellegrini, V. Trischitta, and L. Frittitta
Role of the ENPP1 K121Q Polymorphism in Glucose Homeostasis
Diabetes, December 1, 2008; 57(12): 3360 - 3364.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Vettor, M. Granzotto, D. De Stefani, E. Trevellin, M. Rossato, M. G. Farina, G. Milan, C. Pilon, A. Nigro, G. Federspil, et al.
Loss-of-Function Mutation of the GPR40 Gene Associates with Abnormal Stimulated Insulin Secretion by Acting on Intracellular Calcium Mobilization
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3541 - 3550.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, and R. A. DeFronzo
One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes
Diabetes Care, August 1, 2008; 31(8): 1650 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Abdul-Ghani, M. Matsuda, R. Jani, C. P. Jenkinson, D. K. Coletta, K. Kaku, and R. A. DeFronzo
The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E401 - E406.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. Bonnet, S. Patel, M. Laville, B. Balkau, A. Favuzzi, L. D. Monti, N. Lalic, M. Walker, and on behalf of the European Group for the Study of I
Influence of the ACE Gene Insertion/Deletion Polymorphism on Insulin Sensitivity and Impaired Glucose Tolerance in Healthy Subjects
Diabetes Care, April 1, 2008; 31(4): 789 - 794.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Muniyappa, S. Lee, H. Chen, and M. J. Quon
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E15 - E26.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.